326 related articles for article (PubMed ID: 18415772)
1. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
[TBL] [Abstract][Full Text] [Related]
2. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
[TBL] [Abstract][Full Text] [Related]
3. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
7. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
[TBL] [Abstract][Full Text] [Related]
8. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
9. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis.
Ikezawa-Suzuki I; Shimada Y; Tai H; Komatsu Y; Tanaka A; Yoshie H
J Clin Periodontol; 2008 Nov; 35(11):961-8. PubMed ID: 18823344
[TBL] [Abstract][Full Text] [Related]
10. [Soluble IL-2 receptor levels in rheumatic diseases].
Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S
Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465
[TBL] [Abstract][Full Text] [Related]
11. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder.
Grassi-Oliveira R; Brietzke E; Pezzi JC; Lopes RP; Teixeira AL; Bauer ME
Psychiatry Clin Neurosci; 2009 Apr; 63(2):202-8. PubMed ID: 19175760
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
[TBL] [Abstract][Full Text] [Related]
13. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
Denollet J; Vrints CJ; Conraads VM
Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
[TBL] [Abstract][Full Text] [Related]
14. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
15. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
[TBL] [Abstract][Full Text] [Related]
16. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
[TBL] [Abstract][Full Text] [Related]
17. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.
Dodé C; Papo T; Fieschi C; Pêcheux C; Dion E; Picard F; Godeau P; Bienvenu J; Piette JC; Delpech M; Grateau G
Arthritis Rheum; 2000 Jul; 43(7):1535-42. PubMed ID: 10902757
[TBL] [Abstract][Full Text] [Related]
18. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.
Vilarrasa N; Vendrell J; Sánchez-Santos R; Broch M; Megia A; Masdevall C; Gomez N; Soler J; Pujol J; Bettónica C; Aranda H; Gómez JM
Clin Endocrinol (Oxf); 2007 Nov; 67(5):679-86. PubMed ID: 17608757
[TBL] [Abstract][Full Text] [Related]
19. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
Bariş YS; Yildiz L; Sentürk N; Kandemir B
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
[TBL] [Abstract][Full Text] [Related]
20. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
